REFERENCES
Borre ED, Dubno JR, Myers ER, Emmett SD, Pavon JM, Francis HW, Ogbuoji O, Sanders Schmidler GD. Model-Projected Cost-Effectiveness of Adult Hearing Screening in the USA. J Gen Intern Med. 2023 Mar; 38(4):978-985.
Brewster KK, Deal JA, Lin FR, Rutherford BR. Considering hearing loss as a modifiable risk factor for dementia. Expert Rev Neurother. 2022 Sep;22(9):805-813.
Haddad YK, Miller GF, Kakara R, et al (2024). Healthcare spending for non-fatal falls among older adults, USA. Injury Prevention; 2024; 30:272-276.
Gianattasio KZ, et al. Case Definition for Diagnosed Alzheimer’s Disease and Related Dementias in Medicare. JAMA Network Open. 2024;7(9):e2427610.
Livingston, Gill et al. (2020). Dementia prevention, intervention, and care. The Lancet, Volume 396, Issue 10248, 413-446.
National Center for Health Statistics. Percentage of any difficulty hearing for adults aged 18 and over, United States, 2019—2024. National Health Interview Survey.
Pyenson B, Sawhney TG, Steffens C, Rotter D, Peschin S, Scott J, Jenkins E. The Real-World Medicare Costs of Alzheimer Disease: Considerations for Policy and Care. J Manag Care Spec Pharm. 2019 Jul;25(7):800-809.
Simpson, AN, Matthews, LJ; Cassarly, C; Dubno, JR. Time From Hearing Aid Candidacy to Hearing Aid Adoption: A Longitudinal Cohort Study. Ear and Hearing 40(3):p 468-476, May/June 2019.
Stucky, S.R., Wolf, K.E. and Kuo, T. (2010). The Economic Effect of Age-Related Hearing Loss: National, State, and Local Estimates, 2002 and 2030. Journal of the American Geriatrics Society, 58: 618-619.
White L, Fishman P, Basu A, Crane PK, Larson EB, Coe NB. Medicare expenditures attributable to dementia. Health Serv Res. 2019 Aug;54(4):773-781.
Yeo BSY, Tan VYJ, Ng JH, Tang JZ, Sim BLH, Tay YL, Chowdhury AR, David AP, Jiam NT, Kozin ED, Rauch SD. Hearing Loss and Falls: A Systematic Review and Meta-Analysis. JAMA Otolaryngol Head Neck Surg. 2025 May 1;151(5):485-494.
brain dump 